GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Clinical trial NCT06244368 · RECRUITING

Trial details

NCT number: NCT06244368
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma Diffuse Large B-cell Lymphoma

Start date: 2024-01-17
Primary completion: 2025-12-30
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.